Effects of glucagon-like peptide-1 receptor agonists on mortality and cardiovascular events: A comprehensive meta-analysis of randomized controlled trials
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference24 articles.
1. Lixisenatide in patients with type 2 diabetes and acute coronary syndrome;Pfeffer;N. Engl. J. Med.,2015
2. LEADER steering committee; LEADER trial investigators. Liraglutide and cardiovascular outcomes in type 2 diabetes;Marso;N. Engl. J. Med.,2016
3. SUSTAIN-6 investigators. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes;Marso;N. Engl. J. Med.,2016
4. Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes: differences and similarities;Lund;Eur. J. Intern. Med.,2014
5. Operating characteristics of a rank correlation test for publication bias;Begg;Biometrics,1994
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Several birds with one stone; GLP-1 agonists for the glucose control, weight reduction, and prevention of cardiac and renal outcomes;International Journal of Cardiology;2022-11
2. Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2022;Atención Primaria;2022-10
3. Mini Review: Effect of GLP-1 Receptor Agonists and SGLT-2 Inhibitors on the Growth Hormone/IGF Axis;Frontiers in Endocrinology;2022-02-21
4. Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: An extensive meta-analysis of randomized controlled trials;Nutrition, Metabolism and Cardiovascular Diseases;2021-09
5. Is there a role for glucagon‐like peptide‐1 receptor agonists in the treatment of male infertility?;Andrology;2021-05-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3